NCT00383396已完成4 期
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •pts with symptomatic pterygia unresponsive to palliative treatment.
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseasePrimary Sjogren SyndromeSecondary Sjogren SyndromeAqueous Deficient Dry Eye DiseaseEvaporative Dry Eye DiseaseNCT02004067Federal University of São Paulo100
尚未招募
1 期
Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024Ocular Surface SymptomOcular Surface DiseaseEye PainEye InflammationNCT06624384Mohsen Pourazizi150
已完成
不适用
Topical ciclosporin A eye drops for graft rejectioCorneal graft rejectionInjury, Occupational Diseases, PoisoningFailure and rejection of transplanted organs and tissuesISRCTN52781697Indian Council of Medical Research (ICMR) (India)84
招募中
3 期
Topical cyclosporine 0.05% impact on pterygium recurrence in patients undergoing pterygium surgeryIRCT20160919029871N4Guilan University Of Medical Sciences74
已完成
4 期
Efficacy of Topical Cyclosporin for Ocular RosaceaRosaceaNCT00348335Ophthalmic Consultants of Long Island35